Peter Brøndum-Jacobsen1, Børge G Nordestgaard, Sune F Nielsen, Marianne Benn. 1. Department of Clinical Biochemistry, Herlev Hospital, Herlev, Denmark, Department of Clinical Biochemistry, Gentofte Hospital, Copenhagen, Denmark and Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND: Sun exposure is the single most important risk factor for skin cancer, but sun exposure may also have beneficial effects on health. We tested the hypothesis that individuals with skin cancer (non-melanoma skin cancer and cutaneous malignant melanoma) have less myocardial infarction, hip fracture and death from any cause, compared with general population controls. METHODS: We examined the entire Danish population above age 40 years from 1980 through 2006, comprising 4.4 million individuals. Diagnoses of non-melanoma skin cancer (n=129,206), cutaneous malignant melanoma (n=22,107), myocardial infarction (n=327,856), hip fracture (n=129,419), and deaths from any cause (n=1,629,519) were drawn from national registries. RESULTS: In individuals with vs without non-melanoma skin cancer, multifactorially adjusted odds ratios were 0.96 (95% confidence interval: 0.94-0.98) for myocardial infarction and 1.15 (1.12-1.18) for hip fracture, and the multifactorially adjusted hazard ratio was 0.52 (0.52-0.53) for death from any cause. Risk of hip fracture was reduced (odds ratios were below 1.0) in individuals below age 90 years. In individuals with vs without cutaneous malignant melanoma, corresponding odds ratios were 0.79 (0.74-0.84) for myocardial infarction and 0.84 (0.76-0.93) for hip fracture, and the corresponding hazard ratio for death from any cause was 0.89 (0.87-0.91); however, cutaneous malignant melanoma was associated positively with death from any cause in some individuals. CONCLUSIONS: In this nationwide study, having a diagnosis of skin cancer was associated with less myocardial infarction, less hip fracture in those below age 90 years and less death from any cause. Causal conclusions cannot be made from our data. A beneficial effect of sun exposure per se needs to be examined in other studies.
BACKGROUND: Sun exposure is the single most important risk factor for skin cancer, but sun exposure may also have beneficial effects on health. We tested the hypothesis that individuals with skin cancer (non-melanoma skin cancer and cutaneous malignant melanoma) have less myocardial infarction, hip fracture and death from any cause, compared with general population controls. METHODS: We examined the entire Danish population above age 40 years from 1980 through 2006, comprising 4.4 million individuals. Diagnoses of non-melanoma skin cancer (n=129,206), cutaneous malignant melanoma (n=22,107), myocardial infarction (n=327,856), hip fracture (n=129,419), and deaths from any cause (n=1,629,519) were drawn from national registries. RESULTS: In individuals with vs without non-melanoma skin cancer, multifactorially adjusted odds ratios were 0.96 (95% confidence interval: 0.94-0.98) for myocardial infarction and 1.15 (1.12-1.18) for hip fracture, and the multifactorially adjusted hazard ratio was 0.52 (0.52-0.53) for death from any cause. Risk of hip fracture was reduced (odds ratios were below 1.0) in individuals below age 90 years. In individuals with vs without cutaneous malignant melanoma, corresponding odds ratios were 0.79 (0.74-0.84) for myocardial infarction and 0.84 (0.76-0.93) for hip fracture, and the corresponding hazard ratio for death from any cause was 0.89 (0.87-0.91); however, cutaneous malignant melanoma was associated positively with death from any cause in some individuals. CONCLUSIONS: In this nationwide study, having a diagnosis of skin cancer was associated with less myocardial infarction, less hip fracture in those below age 90 years and less death from any cause. Causal conclusions cannot be made from our data. A beneficial effect of sun exposure per se needs to be examined in other studies.
Entities:
Keywords:
Sun exposure; hip fracture; mortality; myocardial infarction; nationwide study; skin cancer
Authors: Donald Liu; Bernadette O Fernandez; Alistair Hamilton; Ninian N Lang; Julie M C Gallagher; David E Newby; Martin Feelisch; Richard B Weller Journal: J Invest Dermatol Date: 2014-01-20 Impact factor: 8.551
Authors: Mackenzie R Wehner; Wilmarie Cidre Serrano; Adi Nosrati; Patrick Michael Schoen; Mary-Margaret Chren; John Boscardin; Eleni Linos Journal: J Am Acad Dermatol Date: 2017-11-13 Impact factor: 11.527
Authors: Virginia Barton; Kent Armeson; Shalaka Hampras; Laura K Ferris; Kala Visvanathan; Dana Rollison; Anthony J Alberg Journal: Arch Dermatol Res Date: 2017-03-11 Impact factor: 3.017
Authors: Sunni L Mumford; Enrique F Schisterman; Stephen R Cole; Daniel Westreich; Robert W Platt Journal: Epidemiology Date: 2015-01 Impact factor: 4.822
Authors: H A Perroud; M S Dagatti; B Amigot; G P Levit; M F Tomat; M E Morosano; A M Masoni; S M Pezzotto Journal: J Bone Miner Metab Date: 2016-04-02 Impact factor: 2.626